MYLAN is in the news today, with Melbourne’s ,Herald Sun raising concerns that a shortage of its EpiPen product has “left pharmacies in entire country towns and across large sections of cities without the anti-allergy device”.
A shipment of the products is expected next week after a monthlong shortage which has forced Mylan Australia to ration stocks.
Manufacturing delays in the USA are being blamed for the shortage.
Earlier this year Mylan/ Alphapharm initiated a recall of four batches of the 300µg EpiPen adrenaline injection syringe autoinjectors due to a potential failure to activate or a need to apply extra force to activate (d 21 Mar 2017). who received the Distinguished Investigator - Mid-Career Award, after almost 20 years of work as a health practitioner, educator and researcher in mental health and pharmacy practice.
The awards recognise researchers who have made a significant contribution to the field of health services and health policy research in Australia and New Zealand through scholarship and teaching, advancement of science and methods, and leadership.